LONDON (Alliance News) - Glaxosmithkline PLC Wednesday said senior executives, including Chief Executive Andrew Witty and Chief Financial Officer Simon Dingermans, acquired shares under the company share reward plan at a price of 1631.63 pence Monday.<br /><br />Details are as follows.<br /><b Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Tuesday said Simon Bicknall, a divisional vice president, exercised options over 12,650 shares at an exercise price of GBP11.23 per share and sold the shares at GBP16 each Monday. Shares in the healthcare company were up 2.0% at 1,640.09 pence Tu Read More
LONDON (Alliance News) - GlaxoSmithKline PLC said Monday that Chief Executive Officer Andrew Witty disposed of 1,800 shares as gifts in a series of transactions last Friday and on Monday. On Friday, Witty disposed of 50 shares as a gift and transferred 500 shares as a gift to one of his chi Read More
LONDON (Alliance News) - GlaxoSmithKline PLC said Monday that Senior Vice President of Human Resources Claire Thomas bought 33.853 shares following the purchase of shares at 1651.50 pence per share through the re-investment of dividends Friday. Shares in GlaxoSmithKline closed down 0.7% at Read More
LONDON (Alliance News) - AstraZeneca PLC lowered its full-year forecast Thursday, as it saw revenue and pretax profit decline in the full year ended December 31, 2013, due to the loss of exclusivity on several of its brands and increased competition from generics. The pharmaceutical giant p Read More
LONDON (Alliance News) - The FTSE 100 is up for a second day Thursday as the rebound from the heavy losses in equity markets in the previous five days continues, with positive reports from the likes of <strong>Vodafone</strong> and <strong>Smith & Nephew</strong> helping London's blue-chip Read More
LONDON (Alliance News) - The following UK shares received analyst recommendations Thursday morning and Wednesday afternoon:<br />----------<br /><strong>FTSE 100</strong><br />----------<br />S&P CAPITAL IQ CUTS BG GROUP PRICE TARGET TO 1050 (1063) PENCE - 'SELL' <br />----------<br />CRED Read More
LONDON (Alliance News) - <strong>Vodafone</strong> has delivered results in line with expectations Thursday morning, helping to give UK share a positive start. Vodafone is up 1.4%. <br /><br />Meanwhile, <strong>AstraZeneca</strong> has opened down 2.1% after reporting lower revenue and profit Read More
LONDON (Alliance News) - <strong>Vodafone</strong> has delivered results in line with expectations Thursday morning, helping to give UK share a positive start. Vodafone is up 1.4%. <br /><br />Meanwhile, <strong>AstraZeneca</strong> has opened down 2.1% after reporting lower revenue and profit Read More
LONDON (Alliance News) - Mixed data in Europe and the US Wednesday has kept equity markets subdued ahead of the major US jobs report and central bank meetings still to come this week. Meanwhile the pound has underperformed other major currencies after an unexpected drop in UK service sector activ Read More
LONDON (Alliance News) - Drugs giant GlaxoSmithKline PLC Wednesday reported higher fourth quarter profits as revenues increased and it cut costs, and it confirmed that it expects to launch late stage clinical trials on ten new drugs over the next two years. The performance was driven by str Read More
LONDON (Alliance News) - The FTSE 100 is on the verge of snapping a five day losing streak Wednesday, led higher by the likes of<strong> RSA Insurance Group</strong>, which unveiled its new chief executive, and<strong> GlaxoSmithKline</strong>, which has just reported strong results. <br /><br Read More
LONDON (Alliance News) - US stocks are called to open in negative territory Wednesday, having closed firmly higher Tuesday, as investors take a step back ahead of a raft of US macro-economic data. Wall Street shook off recent weaknesses to close higher Tuesday, with the DJIA closing up 0.5% Read More
LONDON (Alliance News) - Drugs giant GlaxoSmithKline PLC Wednesday reported higher fourth quarter profits as revenues increased and it cut costs, and it confirmed that it expects to launch late stage clinical trials on ten new drugs over the next two years. The performance was driven by str Read More
LONDON (Alliance News) - The following is a summary of top news stories Wednesday.<br />----------<br /><strong>COMPANIES</strong><br />----------<br /><strong>Hargreaves Lansdown</strong> PLC reported record pretax profit and revenue for the half year, as it continues to add new clients amid Read More
LONDON (Alliance News) - UK equities are set for yet another negative start Wednesday as investors await a raft of macro-economic data from the UK, the US, and Europe and despite a higher close on Wall Street overnight. Meanwhile, some London-based traders may be struggling to get to their Read More
LONDON (Alliance News) - The FTSE 100 closed lower for a fifth consecutive day Tuesday, even though the index was higher at one point, as concerns about the impact of the Federal Reserve's tapering of its economic stimulus programme continued to weigh on stock markets across the world.<br /><b Read More
LONDON (Alliance News) - The UK's two largest pharmaceuticals companies will report 2013 earnings this week, with AstraZeneca expected to show a fourth quarter loss when it reports Thursday, while GlaxoSmithKline profits are expected to have flatlined over the year as a whole. Both companie Read More